BTNX Inc. stands as a biotechnology company and a global frontrunner in rapid, point-of-care diagnostics. Our focus is on the innovation, research, development, and manufacturing of advanced in-vitro diagnostic (IVD) tests tailored for laboratories, clinics, hospitals, and physicians’ offices. BTNX Inc. also develops information technology systems to manage point-of-care diagnostic test results using HL7/POCT1-A2 compliant software solutions.